We are live on
!
Find out more
SAM
Simplify Asset Management Portfolio holdings
AUM
$7.19B
1-Year Est. Return
6.88%
This Fund
S&P 500
This Quarter
Est. Return
+3.5%
1 Year Est. Return
+6.88%
3 Year Est. Return
+44.98%
5 Year Est. Return
+50.08%
10 Year Est. Return
–
AUM
$7.19B
AUM Growth
+$670M
(+10%)
Cap. Flow
+$523M
Cap. Flow
% of AUM
7.27%
Top 10 Holdings %
Top 10 Hldgs %
91.65%
Holding
163
New
20
Increased
70
Reduced
37
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SBIL
Simplify Government Money Market ETF
SBIL
|
+$311M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$93.2M |
| 3 |
UnitedHealth
UNH
|
+$14.6M |
| 4 |
CAS
Simplify China A Shares PLUS Income ETF
CAS
|
+$11.6M |
| 5 |
PureCycle Technologies
PCT
|
+$11.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$36.1M |
| 2 |
Simplify Short Term Treasury Futures Strategy ETF
TUA
|
+$14.9M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$8.67M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$8.42M |
| 5 |
Align Technology
ALGN
|
+$6.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.05% |
| 2 | Energy | 0.44% |
| 3 | Industrials | 0.38% |
| 4 | Technology | 0.22% |
| 5 | Real Estate | 0.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Ironwood Pharmaceuticals
IRWD
$635M
| – | – |
-11,447
| Closed | -$40.2K |
|
152
3M
MMM
$83.4B
| – | – |
-44,241
| Closed | -$6.43M |
|
153
Oculis Holding
OCS
$736M
| – | – |
-66,667
| Closed | -$1.77M |
|
154
Ovid Therapeutics
OVID
$455M
| – | – |
-130,813
| Closed | -$290K |
|
|
OXLC
155
Oxford Lane Capital
OXLC
$856M
| – | – |
-100,000
| Closed | -$978K |
|
156
Palo Alto Networks
PANW
$292B
| – | – |
-3,967
| Closed | -$636K |
|
157
PepsiCo
PEP
$187B
| – | – |
-1,305
| Closed | -$203K |
|
|
158
Regeneron Pharmaceuticals
REGN
$70.9B
| – | – |
-10,900
| Closed | -$8.42M |
|
159
Trevi Therapeutics
TRVI
$2.71B
| – | – |
-65,412
| Closed | -$780K |
|
160
Vor Biopharma
VOR
$980M
| – | – |
-53,510
| Closed | -$955K |
|
161
Viridian Therapeutics
VRDN
$1.99B
| – | – |
-56,231
| Closed | -$1.1M |
|
|
KLRS
162
Kalaris Therapeutics
KLRS
$104M
| – | – |
-87,426
| Closed | -$504K |
|
|
SAFX
163
XCF Global Inc
SAFX
$170M
| – | – |
-188,857
| Closed | -$69K |
|
Similar funds
CFG
FPP
DS
UB
TSC
FPA
SC
MNA
Simplify Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, Simplify Asset Management held 163 positions worth $7.19B, up 10% from $6.52B the previous quarter. Its ten largest holdings account for 92% of the portfolio.
Simplify Asset Management deployed $523M of net new capital in Q2 2026, opening 20 new positions and adding to 70 existing holdings. Its largest new stake was Simplify China A Shares PLUS Income ETF: 428,078 shares worth $12.4M.
By sector, the portfolio is most concentrated in Healthcare at 5% of assets, up from 3.7% a quarter earlier, followed by Energy and Industrials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $36.1M trimmed.
- Simplify Asset Management's largest Q2 2026 buy was Simplify China A Shares PLUS Income ETF: 428,078 shares worth $12.4M.
- Simplify Asset Management added most to Simplify Government Money Market ETF in Q2 2026, an estimated $311M increase.
- Simplify Asset Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $36.1M.
- Simplify Asset Management fully exited Regeneron Pharmaceuticals in Q2 2026, selling an estimated $8.42M.
- Simplify Asset Management's ten largest holdings make up 92% of its $7.19B portfolio in Q2 2026.
- Simplify Asset Management opened 20 new positions and closed 22 in Q2 2026.
- Simplify Asset Management's portfolio value rose 10% quarter-over-quarter to $7.19B.
Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.